Susquehanna International Group, LLP Kiromic Biopharma, Inc. Call Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$0.6 - $1.82 $19,200 - $58,240	-32,000 Reduced 50.71%	31,100 $26,000
Q4 2021 Feb 14, 2022	SELL	$1.53 - $3.12 $139,995 - $285,480	-91,500 Reduced 59.18%	63,100 $97,000
Q3 2021 Nov 15, 2021	BUY	$2.69 - $4.94 $415,874 - $763,724	154,600 New	154,600 $475,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $15.8M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.